← Leaderboards
John Wesson Ashford
Neurotez, Inc.
$1,365,375
Attributed
$2,730,750
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $946.6K · FY2009–15$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,730,750 · 1
VA$0 · 1
By mechanism
R44$2,730,750 · 1
I01$0 · 1
Top collaborators
- Nikolaos Tezapsidis3 shared
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicPlacebosSafetyAffectRandomizedCognitive FunctionDementiaDaily FunctioningDoseCognitiveAlzheimer&AposAdverse EventAmyloid Beta-ProteinBehaviorBrain ScanAnti-Inflammatory AgentsAnti-InflammatoryBrainAnimalsCalculiAdverse EffectsCh3ocf2ch(Cf3)Och2fCholesterolBiomarker
Grant awards (6)
rTMS for the Treatment of Chronic Pain in GW1 Veterans$0
I01 · FY2015 · VA · contact PI
rTMS for the Treatment of Chronic Pain in GW1 Veterans$0
I01 · FY2014 · VA · contact PI
rTMS for the Treatment of Chronic Pain in GW1 Veterans$0
I01 · FY2013 · VA · contact PI
Leptin as a Therapy for Alzheimer's Disease$946,570
R44 · FY2011 · AG
Leptin as a Therapy for Alzheimer's Disease$944,180
R44 · FY2010 · AG
Leptin as a Therapy for Alzheimer's Disease$840,000
R44 · FY2009 · AG